Primary Care Detection of Cognitive Impairment Leveraging Health & Consumer Technologies in Underserved Communities: The MyCog Trial
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- Northwestern University
- Study ID
- NCT05607732
- Status
- Recruiting
Conditions
- Alzheimer Disease
- Cognitive Decline
- Cognitive Impairment
- Dementia
Eligibility Criteria
- Sex
- ALL
- Age
- 45 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- MyCog — DIAGNOSTIC_TESTMyCog uses well-validated, self-administered, iPad-based measures from the NIH Toolbox for the Assessment of Neurological Behavior and Function Cognition Battery to provide an efficient and sensitive cognitive screen that can be easily implemented in primary care. Preliminary data shows these tests can discriminate between cognitively normal older adults and those with CI (specifically mild cognitive impairment); enabling physicians to assess CI in ways currently not available.
Study Details
Our study intends to offer 'real world' evidence of a viable, sustainable means to mobilize primary care via a comprehensive strategy for detecting cognitive impairment and dementias, advancing next steps for referral, and participating in the care planning and management of affected patients and caregivers. We will conduct a clinic-randomized, pragmatic trial testing the effectiveness and fidelity of our NIH Toolbox-derived paradigm to improve early detection and management of cognitive impairment/dementia in primary care settings serving health disparate patient populations.
Key Dates
- Start date
- Jan 30, 2024
- Status verified
- Mar 2026
- Primary completion
- Oct 30, 2026
- Completion
- Jul 7, 2027
Study Design
- Enrollment
- 45,257 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: MyCog ParadigmThe MyCog paradigm establishes a protocol for implementing our self-administered assessment in the clinic whenever a patient or involved family member reports a concern. The MyCog test can be completed either in the exam room or the waiting room. The MyCog app, on an iPad, can be readily linked to the electronic health record, so once the two tests are completed, results are securely transmitted and will populate within discrete, fields that can be queried found in the patient record; specifically: 1) in a screening tab, under 'cognitive abilities', 2) a flow sheet to capture trend with future repeated tests - informing physicians of a patient's relative vs. normative cognitive decline. Both a binary, objective classification of 'impairment detected or suspected' or 'no impairment detected' will populate in the record, as well as a summary score to further guide the clinician by clarifying the extent to which a patient's performance falls outside a normal threshold.
- No Intervention: Usual Care ArmAt Oak Street Health, cognitive assessments included when concerns are reported by patients or family members, if a clinician suspects a concern, or during Annual Wellness Visits (AWVs) are limited to the Mini-Cog©, and are variably administered, particularly outside of AWVs. Oak Street practices vary by clinician in terms of making referrals, how results are documented, what diagnosis code, placement in problem list or visit diagnosis, and any follow-up plans. While we will not make any explicit recommendations to usual care practices regarding their use of a cognitive assessment, we will ensure that 1) any chosen test is linked to a data field that can be queried in the EHR, and 2) providers receive a compiled list of local medical and non-medical referrals for any detected cases of CI. The Alzheimer's Association recommendations for early detection efforts among primary care practices will be provided to each clinical leadership.
Primary Outcome Measure
Rate of detected impairment [ Time Frame: 3 years ]
Central Contacts
- Michael S Wolf, PhD MPH312-503-5592
- Morgan R Bonham, BS312-503-1813
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Oak Street Health | Chicago | Illinois | 60617 | Justin Hunt, MD Maggie Moran, MPH |
Find similar trials in Chicago, IL
By condition
By specialty
By research site
Related Studies
- Longitudinal Early-onset Alzheimer's Disease Study ProtocolRecruiting · Indiana University · Sun City, Arizona
- Trial-Ready Cohort-Down Syndrome (TRC-DS)Recruiting · University of Southern California · Phoenix, Arizona
- Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older AdultsPHASE4 · Recruiting · Duke University · Birmingham, Alabama
- Late Onset Alzheimer's DiseaseRecruiting · Columbia University · Washington D.C., District of Columbia